{
  "metadata": {
    "case_id": 65,
    "model": "Claude-4.5-Sonnet",
    "timestamp": "2025-11-29T18:00:49.378669",
    "total_alignments": 3,
    "target_section": "protocolSection",
    "ground_truth_path": "/{YOURPATH}/samples/CTG/protocolSection/1_100/65_NCT03988335.json",
    "prediction_path": "/{YOURPATH}/restructured_outputs_protocol/Claude-4.5-Sonnet/65_Claude-4.5-Sonnet.json",
    "shard_range": "1_100"
  },
  "alignments": [
    {
      "field_path": "protocolSection.armsInterventionsModule.armGroups",
      "algorithm": "hungarian",
      "ref_count": 2,
      "pred_count": 2,
      "similarity_matrix": [
        [
          1.0,
          0.2
        ],
        [
          0.7,
          0.98
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 1.0,
          "status": "matched",
          "ref_item": {
            "label": "RIST4721",
            "type": "EXPERIMENTAL",
            "description": "RIST4721 as once-daily 300mg oral solution for 28 days.",
            "interventionNames": [
              "Drug: RIST4721"
            ]
          },
          "pred_item": {
            "label": "RIST4721",
            "type": "EXPERIMENTAL",
            "description": "Subjects received RIST4721 300 mg oral solution once daily for 28 days",
            "interventionNames": [
              "Drug: RIST4721"
            ]
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 1,
          "score": 0.98,
          "status": "matched",
          "ref_item": {
            "label": "Placebo",
            "type": "PLACEBO_COMPARATOR",
            "description": "Placebo as once-daily 300mg oral solution for 28 days.",
            "interventionNames": [
              "Drug: Placebo"
            ]
          },
          "pred_item": {
            "label": "Placebo",
            "type": "PLACEBO_COMPARATOR",
            "description": "Subjects received placebo oral solution once daily for 28 days",
            "interventionNames": [
              "Drug: Placebo"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.armsInterventionsModule.interventions",
      "algorithm": "hungarian",
      "ref_count": 2,
      "pred_count": 2,
      "similarity_matrix": [
        [
          1.0,
          0.4
        ],
        [
          0.15,
          0.98
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 1.0,
          "status": "matched",
          "ref_item": {
            "type": "DRUG",
            "name": "RIST4721",
            "description": "RIST4721 oral solution",
            "armGroupLabels": [
              "RIST4721"
            ]
          },
          "pred_item": {
            "type": "DRUG",
            "name": "RIST4721",
            "description": "RIST4721 300 mg oral solution administered once daily for 28 days. RIST4721 is a small molecule CXCR2 antagonist with high selectivity for CXCR2 over CXCR1 and CCR2b, designed to block neutrophil migration to sites of inflammation.",
            "armGroupLabels": [
              "RIST4721"
            ]
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 1,
          "score": 0.98,
          "status": "matched",
          "ref_item": {
            "type": "DRUG",
            "name": "Placebo",
            "description": "Placebo oral solution",
            "armGroupLabels": [
              "Placebo"
            ]
          },
          "pred_item": {
            "type": "DRUG",
            "name": "Placebo",
            "description": "Placebo oral solution administered once daily for 28 days, matched to RIST4721 in appearance",
            "armGroupLabels": [
              "Placebo"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.primaryOutcomes",
      "algorithm": "hungarian",
      "ref_count": 2,
      "pred_count": 2,
      "similarity_matrix": [
        [
          0.95,
          0.78
        ],
        [
          0.82,
          0.96
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.95,
          "status": "matched",
          "ref_item": {
            "measure": "Log Transformed Ratio of Postbaseline Fresh Pustule Count at Day 28 to Baseline",
            "description": "Relative change from baseline in fresh pustule count at Day 28",
            "timeFrame": "Baseline to Day 28"
          },
          "pred_item": {
            "measure": "Relative change from baseline in fresh pustule count",
            "description": "Relative change from baseline in fresh pustule count at day 28. Fresh pustules were defined as macroscopically visible pustules that were white/yellow in color with no brown color, with or without crust, and present on the glabrous skin of the palms and/or soles.",
            "timeFrame": "Day 28"
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 1,
          "score": 0.96,
          "status": "matched",
          "ref_item": {
            "measure": "Log Transformed Ratio of Postbaseline Total Pustule Count at Day 28 to Baseline",
            "description": "Relative change from baseline in total pustule count at Day 28",
            "timeFrame": "Baseline to Day 28"
          },
          "pred_item": {
            "measure": "Relative change from baseline in total pustule count",
            "description": "Relative change from baseline in total pustule count at day 28. Total pustule count included all pustules present on the palms and/or soles.",
            "timeFrame": "Day 28"
          }
        }
      ]
    }
  ]
}